China Cord Blood (CO) Says $8.3M Left on Current Buyback Plan
Tweet Send to a FriendGet Alerts CO Hot Sheet
Trade CO Now!
China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"), the first and largest cord blood banking operator in China, today announced that the Company repurchased an aggregate of 2,191,412 ordinary shares for a total consideration of approximately $6.2 million since August 2011. The total number of shares repurchased represents approximately 41% of the total $15 million authorized under the existing buyback program, which was authorized by the Board in August 2011, leaving approximately $8.8 million still available for repurchase.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- China Cord Blood Corp. (CO) Tops Q4 EPS by 3c
- Chimera Investment (CIM) Declares $0.09 Quarterly Dividend; Says Book Value $3.55/Share
- Depomed (DEPO) Reports Submission of ANDA for Generic Zipsor
Create E-mail Alert Related Categories
Corporate News, Stock BuybacksLogin with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!

Up)